CAMBRIDGE, Mass.--(BUSINESS WIRE)--ROME Therapeutics, a biotechnology company harnessing the power of the repeatome in drug development, today announced key appointments to its science leadership: ...

Rome Therapeutics has appointed David Proia, Menachem Fromer and Sarah Knutson to its scientific leadership team. The trio join the Fierce 15 winner as it strives to develop cancer and autoimmune ...

Rome's Mayor Walter Veltroni will officiate at the first public viewing of "Rome Reborn 1.0," a 10-year project to use advanced technology to digitally rebuild ancient Rome. An international team of ...